Cargando…
OR01-05 Long-Term Efficacy of T3 Analogue Triac in MCT8 Deficiency
Background: MCT8 deficiency is a severe disorder caused by mutations in the thyroid hormone transporter MCT8. MCT8 deficiency is characterized by severe intellectual and motor disability and high serum T3 concentrations that result in thyrotoxic symptoms in peripheral tissues. This predisposes to su...
Autores principales: | van Geest, Ferdy S, Groeneweg, Stefan, van Toor, Hans, van der Wal, Ronald, de Waart, Monique, van den Berg, Sjoerd Adrianus Antonius, Peeters, Robin Patrick, Visser, W Edward |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7207825/ http://dx.doi.org/10.1210/jendso/bvaa046.1247 |
Ejemplares similares
-
Long-Term Efficacy of T3 Analogue Triac in Children and Adults With MCT8 Deficiency: A Real-Life Retrospective Cohort Study
por: van Geest, Ferdy S, et al.
Publicado: (2021) -
OR14-02 The Thyroid Hormone Analogs DITPA And TRIAC Triggered T3-signalling In Human MCT8-deficient Brain Organoids
por: Salas Lucia, Federico, et al.
Publicado: (2023) -
Insights Into the Mechanism of MCT8 Oligomerization
por: Groeneweg, Stefan, et al.
Publicado: (2020) -
Monocarboxylate transporter 8 deficiency: update on clinical characteristics and treatment
por: van Geest, Ferdy S., et al.
Publicado: (2021) -
SAT-434 Phenotype and Genotype Analysis of Patients with Resistance to Thyroid Hormone β: A Single-Center Experience
por: Wejaphikul, Karn, et al.
Publicado: (2020)